Dennis Mulroy - Net Worth and Insider Trading

Dennis Mulroy Net Worth

The estimated net worth of Dennis Mulroy is at least $25,677 dollars as of 2024-05-11. Dennis Mulroy is the CHIEF FINANCIAL OFFICER of AnaptysBio Inc and owns about 964 shares of AnaptysBio Inc (ANAB) stock worth over $22,567. Dennis Mulroy is also the CFO of La Jolla Pharmaceutical Co and owns about 500 shares of La Jolla Pharmaceutical Co (LJPC) stock worth over $3,110. Details can be seen in Dennis Mulroy's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Dennis Mulroy has not made any transactions after 2024-01-30 and currently still holds the listed stock(s).

Transaction Summary of Dennis Mulroy

To

Dennis Mulroy Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Dennis Mulroy owns 3 companies in total, including AnaptysBio Inc (ANAB) , La Jolla Pharmaceutical Co (LJPC) , and Gene Biotherapeutics Inc (CRXM) .

Click here to see the complete history of Dennis Mulroy’s form 4 insider trades.

Insider Ownership Summary of Dennis Mulroy

Ticker Comapny Transaction Date Type of Owner
ANAB AnaptysBio Inc 2024-01-30 Chief Financial Officer
LJPC La Jolla Pharmaceutical Co 2017-03-03 Chief Financial Officer
CRXM Gene Biotherapeutics Inc 2014-02-28 Chief Financial Officer

Dennis Mulroy Latest Holdings Summary

Dennis Mulroy currently owns a total of 2 stocks. Among these stocks, Dennis Mulroy owns 964 shares of AnaptysBio Inc (ANAB) as of January 30, 2024, with a value of $22,567 and a weighting of 87.89%. Dennis Mulroy also owns 500 shares of La Jolla Pharmaceutical Co (LJPC) as of March 3, 2017, with a value of $3,110 and a weighting of 12.11%.

Latest Holdings of Dennis Mulroy

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ANAB AnaptysBio Inc 2024-01-30 964 23.41 22,567
LJPC La Jolla Pharmaceutical Co 2017-03-03 500 6.22 3,110

Holding Weightings of Dennis Mulroy


Dennis Mulroy Form 4 Trading Tracker

According to the SEC Form 4 filings, Dennis Mulroy has made a total of 3 transactions in AnaptysBio Inc (ANAB) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in AnaptysBio Inc is the sale of 3,065 shares on January 30, 2024, which brought Dennis Mulroy around $72,426.

According to the SEC Form 4 filings, Dennis Mulroy has made a total of 0 transactions in La Jolla Pharmaceutical Co (LJPC) over the past 5 years. The most-recent trade in La Jolla Pharmaceutical Co is the acquisition of 500 shares on March 3, 2017, which cost Dennis Mulroy around $16,975.

Insider Trading History of Dennis Mulroy

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Dennis Mulroy Trading Performance

GuruFocus tracks the stock performance after each of Dennis Mulroy's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Dennis Mulroy is -13.99%. GuruFocus also compares Dennis Mulroy's trading performance to market benchmark return within the same time period. The performance of stocks bought by Dennis Mulroy within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Dennis Mulroy's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Dennis Mulroy

Average Return

Average return per transaction

Outperforming Transactions

0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -13.58
Relative Return to S&P 500(%) -12.56

Dennis Mulroy Ownership Network

Ownership Network List of Dennis Mulroy

No Data

Ownership Network Relation of Dennis Mulroy


Dennis Mulroy Owned Company Details

What does AnaptysBio Inc do?

Who are the key executives at AnaptysBio Inc?

Dennis Mulroy is the Chief Financial Officer of AnaptysBio Inc. Other key executives at AnaptysBio Inc include General Counsel Eric J Loumeau , Chief Medical Officer Paul F. Lizzul , and 10 percent owner Ecor1 Capital, Llc .

AnaptysBio Inc (ANAB) Insider Trades Summary

Over the past 18 months, Dennis Mulroy made 3 insider transaction in AnaptysBio Inc (ANAB) with a net sale of 11,245. Other recent insider transactions involving AnaptysBio Inc (ANAB) include a net sale of 14,187 shares made by Eric J Loumeau , a net sale of 155,806 shares made by Daniel Faga , and a net sale of 4,659 shares made by Paul F. Lizzul .

In summary, during the past 3 months, insiders sold 153,940 shares of AnaptysBio Inc (ANAB) in total and bought 0 shares, with a net sale of 153,940 shares. During the past 18 months, 185,897 shares of AnaptysBio Inc (ANAB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 185,897 shares.

AnaptysBio Inc (ANAB)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

AnaptysBio Inc Insider Transactions

No Available Data

Dennis Mulroy Mailing Address

Above is the net worth, insider trading, and ownership report for Dennis Mulroy. Currently GuruFocus does not have mailing address information for Dennis Mulroy.

Discussions on Dennis Mulroy

No discussions yet.